FDA.reportPublic FDA data

6 ML obiltoxaximab 100 MG/ML Injection

RxCUI
1746910
RxNorm name
6 ML obiltoxaximab 100 MG/ML Injection
Display name
6 ML obiltoxaximab 100 MG/ML Injection
Full name
6 ML obiltoxaximab 100 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125509Anthimobiltoxaximab351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
39ad8799-00a4-4fc8-9852-c0536350c474obiltoxaximab 600 MG in 6 ML Injection [PSN] · 6 ML obiltoxaximab 100 MG/ML Injection [SCD] · obiltoxaximab 600 MG per 6 ML Injection [SY]39These highlights do not include all the information needed to use ANTHIM safely and effectively. See full prescribing information for ANTHIM. ANTHIM ® (obiltoxaximab) injection, for intravenous use Initial U.S. Approval: 201620251117